Evidence
The University of Oxford is part of country-wide trials to identify accurate and quick blood tests that can diagnose dementia.
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Blood tests for diagnosing dementia a step closer
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Sildenafil (‘Viagra’) improves brain blood flow and could help to prevent dementia
- Presentation: Regulating Advanced AI Systems - Oxford Martin AI Governance Initiative
- Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia
- Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- Predicting cognitive function and dementia risk in patients with hypertension
- The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial
- The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial
- Clinical characteristics of older patients with suspected or diagnosed dementia during hospitalization
- Clinical characteristics of older patients with suspected or diagnosed dementia during hospitalization
- Clinical characteristics of older patients with suspected or diagnosed dementia during hospitalization
- 2024 Oxford University of Sanctuary Fair
- Exercised-enriched blood plasma rescues hippocampal impairments and cognitive deficits in an Alzheimer's disease model
- Updates from the IOI with Sir Stewart Cole and Prof Craig Maclean
- Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease
- Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance
- Cardiac output-mediated regulation of cerebral blood flow during exercise: Clinical perspectives on the indirect impact of muscle metaboreflex
- Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM)
- Ageing-Related Neurodegeneration and Cognitive Decline
- Differences in cognitive trajectories of dementia: Comparison Alzheimer's disease dementia and Dementia with Lewy bodies in Korean patient cohort
- Vitamin D, Alzheimer's disease and related dementia
- Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia
- A Multi-modal Classification Method for Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease Using Three Paradigms with Various Task Difficulties
- Association of exposure to ambient air pollutants with cognitive performance and dementia risk and the mediating role of pulmonary function: Evidence from the UK Biobank
- Dementia with Lewy bodies: Primary care PAs can make this difficult diagnosis
- Things to know about AI for your career
- Enhancing Dementia Risk Mitigation: Standardized Digital Monitoring in Clinical Trials and Platform Design for At-Risk Elderly Individuals
- A qualitative study of informal caregiver perceptions of the benefits of an early dementia diagnosis
- Monitoring risk factors for dementia in middle-aged and older adults: a longitudinal study
- The Pandemic EVIDENCE Collaboration programme launch
- MFO / OxPo WORKSHOP ‘2024 European election results: Change and continuity’
- Oxygen tug-of-war, voxelotor, and the brain
- New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites
- 'Using co-design of technology to unlock possibilities for music interaction with people living with dementia'
- Moving forward with dementia: an explorative cross-country qualitative study into post-diagnostic experiences
- Bidirectional relationship between late-onset epilepsy (LOE) and dementia: A systematic review and meta-analysis of cohort studies
- Alzheimer blood biomarkers: practical guidelines for study design, sample collection, processing, biobanking, measurement and result reporting
- Risk factors for faster aging in the brain revealed in new study
- A Novel Computerized Flexible Attention Test in Detecting Executive Dysfunction of Patients with Early-Onset Cognitive Impairment and Dementia
- Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson's disease
- Effect of Population-Level Blood Pressure Treatment Strategies on Cardiovascular and Cognitive Outcomes
- What are the Correlates of Hearing Aid Use for People Living With Dementia?
- Donor Muse Cell Treatment Without HLA-Matching Tests and Immunosuppressant Treatment
- Impaired Kidney Function, Cerebral Small Vessel Disease and Cognitive Disorders: The Framingham Heart Study
- Migration and asylum in the Americas: interdisciplinary perspectives
- Oxford Surgical Trials Training Day 2024
- Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease
- The landscape of inequalities in dementia across Europe: First insights from the INTERDEM taskforce
- A feasibility and pilot study of a "lifelong learning" intervention for people with dementia
- The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia
- Sources and perceptions of hope: A qualitative study involving younger people with dementia
- Genetic evidence for the causal relationships between migraine, dementia, and longitudinal brain atrophy
- Internet use statistically associated with higher wellbeing, finds new global Oxford study
- Internet use statistically associated with higher wellbeing, finds new global Oxford study
- Association between Multiple Trace Elements, Executive Function, and Cognitive Impairment with No Dementia in Older Adults
- Detecting Misfolded a-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease
- Riddles in the Grass: the characterisation and narrative value of landscape over the fields of Rohan
- More local school children join sport and education sessions at Oxford as expanded community programme returns
- Work-, lifestyle-, and health-related factors among women and men working in the emergency medical services
- Improving Conversations about Parkinson's Dementia
- Dementia Risk Awareness, Health Behaviors and Motivation for Dementia Prevention in Middle-Aged and Older Adults in Turkiye
- Placenta-brain communication in preeclampsia. What we have learnt from preclinical models.
- Dementia Friendly Communities: Micro-processes and practices observed locally in Queensland Australia
- A preliminary study on identification of the blood donor in a body fluid mixture using a novel compound genetic marker blood-specific methylation-microhaplotype
Evidence Blueprint
Blood tests for diagnosing dementia a step closer
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Blood tests for diagnosing dementia a step closer
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Sildenafil (‘Viagra’) improves brain blood flow and could help to prevent dementia
- Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis
- The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa
- Presentation: Regulating Advanced AI Systems - Oxford Martin AI Governance Initiative
- Understanding Cognitive Deficits in People with High Blood Pressure
- New Oxford study sheds light on the origin of animals
- Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer's Disease
- Visual processing speed and its association with future dementia development in a population-based prospective cohort: EPIC-Norfolk
- Bayesian genome-wide TWAS with reference transcriptomic data of brain and blood tissues identified 141 risk genes for Alzheimer's disease dementia
- Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum
- Oxford University to mark 70th anniversary of Sir Bannister’s four-minute mile with local community
- Blood biomarkers open a window to brain pathophysiology in Alzheimer's disease
- The diagnostic value of cognitive assessment indicators for mild cognitive impairment (MCI)
- University will host numerous activities and openings for Oxford Open Doors 2023
- Regius Professor of Medicine, Sir John Bell, to step down from Oxford role
- Oxford-Harrington Rare Disease Centre Launches Pioneering Therapeutics Accelerator to Advance Innovative Treatments for Rare Diseases
- The scope of using pragmatic language tests for early detection of dementia: A systematic review of investigations using figurative language
- Researchers develop a blood test to identify individuals at risk of developing Parkinson’s disease
- Who tests for lead and why? A 10-year analysis of blood lead screening, follow-up and CNS outcomes in a statewide US healthcare system
- Global impact of Oxford University Innovation highlighted in new report
- A Hospital Based Observational Study to Detect Non-Alcoholic Steatohepatitis by Acoustic Radiation Force Impulse in Individuals with Diabetes Mellitus and Metabolic Syndrome
- Neuropsychological tests used for dementia assessment in Japan: Current status
- Diagnostic and prognostic performance of the SAFE score in non-alcoholic fatty liver disease
- Mild Cognitive Impairment Progression and Alzheimer's Disease Risk: A Comprehensive Analysis of 3553 Cases over 203 Months
- Predicting cognitive function and dementia risk in patients with hypertension
- Tests for consciousness in humans and beyond
- University of Oxford named Focused Ultrasound Centre of Excellence
- Dementia in South Africa: A Situational Analysis
- The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial
- The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trial
- Year-by-Year Blood Pressure Variability From Midlife to Death and Lifetime Dementia Risk
- Clinical characteristics of older patients with suspected or diagnosed dementia during hospitalization
- Clinical characteristics of older patients with suspected or diagnosed dementia during hospitalization
- Clinical characteristics of older patients with suspected or diagnosed dementia during hospitalization
- 2024 Oxford University of Sanctuary Fair
- Exercised-enriched blood plasma rescues hippocampal impairments and cognitive deficits in an Alzheimer's disease model
- Updates from the IOI with Sir Stewart Cole and Prof Craig Maclean
- Medicolegal pitfalls when assessing decision-making capacity in people with cognitive impairment
- Validating blood tests as a possible routine diagnostic assay of Alzheimer's disease
- Orthostatic Blood Pressure Change, Dizziness, and Risk of Dementia in the ARIC Study: Dementia Series
- Does the presence of chronic pain affect scores on cognitive screening tests/brief cognitive measures for dementia? A systematic review and meta-analysis
- The relationship between social cognitive processes and behavior changes in people with amnestic mild cognitive impairment or dementia using the Edinburgh Social Cognition Test (ESCoT)
- Psychometric properties of the Caregiver's inventory neuropsychological diagnosis dementia (CINDD) in mild cognitive impairment and dementia
- Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers
- Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease
- Oxford University is the world’s top university for a record eighth year
- Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance
- Applications of Artificial Intelligence in the Neuropsychological Assessment of Dementia: A Systematic Review
- Cardiac output-mediated regulation of cerebral blood flow during exercise: Clinical perspectives on the indirect impact of muscle metaboreflex
- New Oxford research hub to propel transformative AI innovations
- Major boost for Oxford University's battery research
- Gut microbiota in combination with blood metabolites reveals characteristics of the disease cluster of coronary artery disease and cognitive impairment: a Mendelian randomization study
- Development and validation of the Michigan Chronic Disease Simulation Model (MICROSIM)
- Causal relationship between gut microflora and dementia: a Mendelian randomization study
- A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer's disease
- Ageing-Related Neurodegeneration and Cognitive Decline
- Differences in cognitive trajectories of dementia: Comparison Alzheimer's disease dementia and Dementia with Lewy bodies in Korean patient cohort
- Vitamin D, Alzheimer's disease and related dementia
- Causal associations between common musculoskeletal disorders and dementia: a Mendelian randomization study
- Access to primary eye care for people living with dementia: a call to action for primary care practitioners to 'think vision'
- Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer's disease
- The usefulness of point-of-care ultrasound in dehydrated patients in a pediatric emergency department
- Peripheral blood amyloid-β involved in the pathogenesis of Alzheimer's disease via impacting on peripheral innate immune cells
- Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia
Inoxford, university